Hi, what are you looking for?
IceCure Medical, BrainStorm Cell Therapeutics, and NeuroSense Therapeutics are three Israeli medtech firms that all made new moves this week. BrainStorm Cell Therapeutics Inc.,...
Phase III trials of BrainStorm's ALS treatment NurOwn showed no progress.
Clinical Trial Results Provide Strong Indication That Stem Cell Treatment Inhibits ALS Disease Progression In 87 percent of Patients
"This patent allowance in Israel further extends the geographic reach of our intellectual property."
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the Data and Safety Monitoring Board (DSMB) met...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced positive results from preclinical studies of its NurOwn in...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced positive final results from its phase 2a clinical trial...
BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the US Food and Drug Administration has designated...
– Brainstorm Cell Therapeutics Ltd. (Bulletin Board:BCLI) is expected to receive a $5 million grant from the Brazilian Ministry of Health. The grant is...
GroupMap has rolled out a new version of its online brainstorming software aimed at providing real time collaboration in group settings.